Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand.
School of Pharmacy, University of Auckland, Auckland, New Zealand.
PLoS One. 2024 Aug 29;19(8):e0307971. doi: 10.1371/journal.pone.0307971. eCollection 2024.
Pertussis vaccination is recommended during pregnancy to protect the baby. Pertussis vaccination was initially free to pregnant people through general practice and hospitals in New Zealand, but uptake was suboptimal. In one district funding of maternal pertussis vaccination was widened to community pharmacies in 2016. Eighteen months later promotion to pharmacies, midwives and pregnant people took place. In 2020 and 2021, COVID-19 lockdowns occurred.
To explore the effects of promotion and COVID-19 lockdowns on uptake of funded maternal pertussis vaccination in pharmacy, and awareness, use and opinions of promotional elements.
Five years of pharmacy claims data were analysed and 12 pharmacists, 18 people eligible/recently eligible for maternal pertussis vaccination and 11 midwives were interviewed.
Provision of maternal pertussis vaccination increased during and after promotion. Qualitative data showed that pharmacists valued phone calls with information about maternal pertussis vaccination and recommendations for increasing uptake. Prompted by these calls, some pharmacists contacted midwives to inform them of funded maternal pertussis vaccination in the pharmacy (which midwives appreciated) and recommended pertussis vaccination to pregnant clients. Pharmacy staff reportedly were motivated to recommend this vaccination by being informed about it and having posters displayed in the pharmacy. Pregnant people valued healthcare professionals' conversations about maternal pertussis vaccination, but appeared to be uninfluenced by posters and promotional social media posts about this vaccination. During COVID-19, maternal pertussis uptake in pharmacies increased 31% March to May 2020 (before and during the first COVID-19 lockdown) versus the same time the previous year, then declined.
Promotion appeared to have a sustained effect on uptake of maternal pertussis vaccination in pharmacies. Pregnant people were most influenced by discussions with healthcare professionals. Pharmacists and pharmacy staff increased proactivity with maternal vaccinations after promotion to them. Promotion may need to be repeated over time.
百白破疫苗接种被推荐用于孕妇,以保护婴儿。在新西兰,百白破疫苗最初通过全科医生和医院向孕妇免费提供,但接种率不理想。2016 年,一个地区扩大了社区药房为孕妇接种百白破疫苗的资金来源。18 个月后,对药房、助产士和孕妇进行了推广。2020 年和 2021 年,新西兰发生了 COVID-19 封锁。
探讨推广和 COVID-19 封锁对药房资助的孕妇百白破疫苗接种的影响,以及对推广要素的认识、使用和意见。
分析了五年的药房报销数据,并对 12 名药剂师、18 名符合条件/最近符合资格接受百白破疫苗接种的孕妇和 11 名助产士进行了访谈。
在推广期间和之后,提供了百白破疫苗。定性数据显示,药剂师重视有关百白破疫苗接种的电话咨询和提高接种率的建议。受这些电话的启发,一些药剂师联系助产士,告知她们在药房提供的资助性孕妇百白破疫苗接种情况(助产士对此表示赞赏),并向孕妇客户推荐百白破疫苗接种。据报道,药剂师因了解该疫苗并在药房展示海报而受到激励,从而推荐该疫苗接种。孕妇重视医疗保健专业人员关于百白破疫苗接种的对话,但似乎不受该疫苗接种的海报和推广的社交媒体帖子的影响。在 COVID-19 期间,2020 年 3 月至 5 月(第一次 COVID-19 封锁之前和期间)药房的孕妇百白破疫苗接种率比前一年同期增加了 31%,然后下降。
推广似乎对药房的孕妇百白破疫苗接种率有持续的影响。孕妇最受与医疗保健专业人员的对话影响。推广后,药剂师和药房工作人员对孕妇疫苗接种的积极性提高。随着时间的推移,可能需要重复推广。